Test your basic knowledge |

First Aid Basics

Instructions:
  • Answer 50 questions in 15 minutes.
  • If you are not ready to take this test, you can study here.
  • Match each statement with the correct term.
  • Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Malignant lymphoma






2. AA






3. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)






4. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.






5. Leiomyoma






6. Osteoma






7. Neurofibromatosis type 1 17q tumor suppressor






8. Melanoma - basal cell carcinoma - and especially squamous cell carcinomas of the skin.






9. Anaplasia - neoplasia - desmoplasia (fibrous tissue formation in response to neoplasm)






10. Adenoma - papilloma






11. Solid tissues with single blood supply. Heart - kidney and spleen.






12. Rhabdomyoma






13. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor






14. Colorectal cancer (assoc with FAP) 5q tumor suppressor






15. Lymphoma

Warning: Invalid argument supplied for foreach() in /var/www/html/basicversity.com/show_quiz.php on line 183


16. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.






17. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.






18. Secondary osteosarcoma and fibrosarcoma

Warning: Invalid argument supplied for foreach() in /var/www/html/basicversity.com/show_quiz.php on line 183


19. During embryogenesis - hormone induction and atrophy. Increased mitochondrial permeability and cytochrome c release. Increase Bax (pro - apoptotic) - decreased Bcl -2 (anti - apopotic).






20. Ligand - receptor interactions. Release of perforin and granzyme B.






21. Adenocarcinoma - papillary carcinoma






22. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)






23. Antibodies to presynaptic Ca2+ channels at NM junction






24. Erythropoietin






25. Tumor marker: carcinoembryonic Ag Very nonspecific






26. Lung (mesothelioma and bronchogenic carcinoma)






27. Skin (SqCC) - liver (angiosarcoma)






28. Vascular: E and P- selectin Leukocyte: Sialyl Lewis






29. Aggressive malignant lymphomas (non - Hodgkin's) and Kaposi's sarcoma






30. Lung - breast - skin (melanoma) - kidney (renal cell carcinoma) - GI.50% brain tumors are from mets






31. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)






32. Vascular: ICAM-1 Leukocyte: LFA-1 (integrin)






33. Colonic adenocarcinoma






34. Enzymatic degradation and protein denaturation due to exogenous injury. Inflammatory process where intracellular components extravasate.






35. Hyperuricemia (excess NA turnover)






36. Breast cancer 13q tumor suppressor (DNA repair protein)






37. Liver (centrilobular necrosis - fatty change)






38. TB - fungal infections - syphilis - leprosy - cat scratch fever - sarcoid - Crohn's - Berylliosis.






39. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)






40. Bacterial products (CLIK):C5a - LTB4 - IL-8 - Kallikrein






41. Sickle cell (altered shape) - polycythemia (too many) - CHF (unknown)






42. Liposarcoma






43. Blood (leukemia)






44. Bladder (transitional cell carcinoma)






45. Tumor marker: mets to bone - obstructive biliary disease - Paget's






46. ADH






47. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)






48. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.






49. Hyperplasia - metaplasia - dysplasia






50. Gastric adenocacinoma